NCT05359965View on ClinicalTrials.gov

Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

July 31, 2025

Study Completion Date

September 1, 2025

Conditions
Idiopathic Pulmonary FibrosisObstructive Sleep ApneaGastro Esophageal Reflux
Interventions
DEVICE

Positive Airway Pressure

Gentle and steady pressure (with or without supplemental oxygen) delivered to the airways of the lungs while subjects are sleeping.

Trial Locations (1)

85724

University of Arizona, Tucson

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

University of Arizona

OTHER

NCT05359965 - Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF | Biotech Hunter | Biotech Hunter